US ETFDetailed Quotes

COYA Coya Therapeutics

Watchlist
  • 6.850
  • -0.190-2.70%
Close Nov 4 16:00 ET
  • 6.850
  • 0.0000.00%
Post 20:01 ET
113.71MMarket Cap-9256P/E (TTM)

Coya Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
3.43M
126.84K
6M
6M
0
0
0
0
0
0
Operating revenue
--3.43M
--126.84K
--6M
--6M
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
104.69%6.66M
93.44%5.61M
41.72%13.91M
108.98%4.19M
33.89%3.56M
-5.57%3.25M
70.56%2.9M
101.46%9.81M
25.37%2M
2.66M
Selling and administrative expenses
14.15%2.09M
46.84%2.44M
61.61%7.83M
164.55%2.38M
58.96%1.96M
-8.28%1.83M
131.57%1.66M
109.64%4.85M
22.74%898.65K
--1.24M
-General and administrative expense
14.15%2.09M
46.84%2.44M
61.61%7.83M
164.55%2.38M
58.96%1.96M
-8.28%1.83M
131.57%1.66M
109.64%4.85M
22.74%898.65K
--1.24M
Research and development costs
222.02%4.57M
156.81%3.16M
22.42%6.04M
64.19%1.8M
12.66%1.59M
-2.03%1.42M
25.84%1.23M
94.23%4.94M
28.30%1.1M
--1.41M
Depreciation amortization depletion
0.00%6.84K
0.00%6.84K
0.00%27.36K
0.00%6.84K
-45.07%6.84K
69.60%6.84K
69.60%6.84K
69.60%27.36K
-32.86%6.84K
--12.46K
-Depreciation and amortization
0.00%6.84K
0.00%6.84K
0.00%27.36K
0.00%6.84K
-45.07%6.84K
69.60%6.84K
69.60%6.84K
69.60%27.36K
-32.86%6.84K
--12.46K
Operating profit
0.56%-3.24M
-89.06%-5.48M
19.45%-7.9M
190.60%1.82M
-33.89%-3.56M
5.57%-3.25M
-70.56%-2.9M
-101.46%-9.81M
-25.37%-2M
-2.66M
Net non-operating interest income expense
Other net income (expense)
116.67%344.45K
163.45%431.09K
126.28%639.37K
115.82%174.67K
110.46%142.09K
377.60%158.97K
5,523.73%163.63K
-11,225.00%-2.43M
-3,401.68%-1.1M
-1.36M
Gain on sale of security
----
----
----
----
----
----
----
---2.5M
---1.12M
---1.4M
Other non- operating income (expenses)
116.67%344.45K
163.45%431.09K
904.14%639.37K
969.64%174.67K
260.45%142.09K
1,353.11%158.97K
5,523.73%163.63K
396.40%63.67K
151.79%16.33K
--39.42K
Income before tax
6.58%-2.89M
-84.61%-5.05M
40.68%-7.26M
164.03%1.99M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
-4.02M
Income tax
723.85K
0
Net income
6.58%-2.89M
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
-4.02M
Net income continuous Operations
6.58%-2.89M
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
---4.02M
Minority interest income
Net income attributable to the parent company
6.58%-2.89M
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
-4.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
6.58%-2.89M
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
-4.02M
Basic earnings per share
38.71%-0.19
-25.00%-0.35
83.30%-0.79
146.72%0.15
18.15%-0.34
40.02%-0.31
-8.54%-0.28
-538.47%-4.73
-30.09%-0.3211
-0.4154
Diluted earnings per share
38.71%-0.19
-25.00%-0.35
83.30%-0.79
146.72%0.15
18.15%-0.34
40.02%-0.31
-8.54%-0.28
-538.47%-4.73
-30.09%-0.3211
-0.4154
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 3.43M126.84K6M6M000000
Operating revenue --3.43M--126.84K--6M--6M--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 104.69%6.66M93.44%5.61M41.72%13.91M108.98%4.19M33.89%3.56M-5.57%3.25M70.56%2.9M101.46%9.81M25.37%2M2.66M
Selling and administrative expenses 14.15%2.09M46.84%2.44M61.61%7.83M164.55%2.38M58.96%1.96M-8.28%1.83M131.57%1.66M109.64%4.85M22.74%898.65K--1.24M
-General and administrative expense 14.15%2.09M46.84%2.44M61.61%7.83M164.55%2.38M58.96%1.96M-8.28%1.83M131.57%1.66M109.64%4.85M22.74%898.65K--1.24M
Research and development costs 222.02%4.57M156.81%3.16M22.42%6.04M64.19%1.8M12.66%1.59M-2.03%1.42M25.84%1.23M94.23%4.94M28.30%1.1M--1.41M
Depreciation amortization depletion 0.00%6.84K0.00%6.84K0.00%27.36K0.00%6.84K-45.07%6.84K69.60%6.84K69.60%6.84K69.60%27.36K-32.86%6.84K--12.46K
-Depreciation and amortization 0.00%6.84K0.00%6.84K0.00%27.36K0.00%6.84K-45.07%6.84K69.60%6.84K69.60%6.84K69.60%27.36K-32.86%6.84K--12.46K
Operating profit 0.56%-3.24M-89.06%-5.48M19.45%-7.9M190.60%1.82M-33.89%-3.56M5.57%-3.25M-70.56%-2.9M-101.46%-9.81M-25.37%-2M-2.66M
Net non-operating interest income expense
Other net income (expense) 116.67%344.45K163.45%431.09K126.28%639.37K115.82%174.67K110.46%142.09K377.60%158.97K5,523.73%163.63K-11,225.00%-2.43M-3,401.68%-1.1M-1.36M
Gain on sale of security -------------------------------2.5M---1.12M---1.4M
Other non- operating income (expenses) 116.67%344.45K163.45%431.09K904.14%639.37K969.64%174.67K260.45%142.09K1,353.11%158.97K5,523.73%163.63K396.40%63.67K151.79%16.33K--39.42K
Income before tax 6.58%-2.89M-84.61%-5.05M40.68%-7.26M164.03%1.99M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M-4.02M
Income tax 723.85K0
Net income 6.58%-2.89M-84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M-4.02M
Net income continuous Operations 6.58%-2.89M-84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M---4.02M
Minority interest income
Net income attributable to the parent company 6.58%-2.89M-84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M-4.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 6.58%-2.89M-84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M-4.02M
Basic earnings per share 38.71%-0.19-25.00%-0.3583.30%-0.79146.72%0.1518.15%-0.3440.02%-0.31-8.54%-0.28-538.47%-4.73-30.09%-0.3211-0.4154
Diluted earnings per share 38.71%-0.19-25.00%-0.3583.30%-0.79146.72%0.1518.15%-0.3440.02%-0.31-8.54%-0.28-538.47%-4.73-30.09%-0.3211-0.4154
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data